Evidence map›Paper›PMID 31782114›Full record

ReviewClinical journal of gastroenterology2020

Isolated cardiac metastases of hepatocellular carcinoma after resection: a case report.

Yosuke Tamura, Tomokazu Kawaoka, Hiroshi Aikata, Maiko Namba, Yasutomo Fujii, Kei Morio, Eisuke Murakami, Masami Yamauchi, Akira Hiramatsu, Takashi Nakahara and 8 more

Abstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Clinical journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Yosuke TamuraDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Tomokazu KawaokaDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan. kawaokatomo@hiroshima-u.ac.jp.ORCID http://orcid.org/0000-0002-1887-1096
Hiroshi AikataDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Maiko NambaDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Yasutomo FujiiDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Kei MorioDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Eisuke MurakamiDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Masami YamauchiDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Akira HiramatsuDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Takashi NakaharaDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Michio ImamuraDepartment of Gastroenterology and Metabolism, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Tatsuya MaruhashiDepartment of Cardiovascular Medicine, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Tsuyoshi KobayashiDepartment of Gastroenterological and Transplant Surgery, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Hideki OhdanDepartment of Gastroenterological and Transplant Surgery, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Tomoki KimuraDepartment of Radiation Oncology, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Yasushi NagataDepartment of Radiation Oncology, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Kouji ArihiroDepartment of Anatomical Pathology, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan.
Kazuaki Chayama
Hiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 76-year-old man was diagnosed with multiple hepatocellular carcinomas (HCCs). He underwent right lobectomy and partial resection of the liver after transcatheter arterial embolization at our hospital. The pathology report was moderately differentiated HCC (fT4N0M0 Stage Iva, Vp1, Vv0). Follow-up CT revealed a lesion in the right ventricle 3 years after surgery. Moderately differentiated HCC was determined on myocardial biopsy, and the lesion was diagnosed as cardiac metastasis of HCC. No recurrence of HCC was observed in the liver. Radiation therapy (39 Gy/13 fr) was performed for the cardiac metastasis, and oral lenvatinib 8 mg/day was started. Evaluation by mRECIST on contrast-enhanced CT indicate a partial response (PR). Lenvatinib has been continued for 7 months. Cardiac metastasis of HCC is extremely rare; herein, we have also provided a literature reviews.

Indexed as

AgedCarcinoma, HepatocellularChemoembolization, TherapeuticHeart NeoplasmsHepatectomyHumansLiver NeoplasmsMaleHepatocellular carcinomaIsolated cardiac metastasisLenvatinibRadiation therapy

Identifiers

PMID31782114
OpenAlexW2989860177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.